drugset / Trial / NCT05916690

Electrochemotherapy for the Treatment of Vulvar Cancer

NCT05916690

Unknown 20 enrolled Institute of Oncology Ljubljana
NaSingle-groupOpen-labelTreatment

Summary

Electrochemotherapy is a local treatment modality with effectiveness comparable to other local ablation techniques. With electrochemotherapy 80% objective response can be achieved and is suitable for the treatment of different types of tumors. The method is based on increased drug delivery to cells previously exposed to electroporation. The most commonly used cytotoxic agents are bleomycin and cisplatin. The aim of the proposed clinical trial is to determine the efficacy, feasibility and safety of electrochemotherapy in the treatment of vulvar cancer.

Timeline

Start
2021-03-01
Primary completion
2024-12-31
Completion
2025-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Bleomycin Unknown
Subject Cisplatin Other / unclassified

Indications